COMMUNIQUÉS West-GlobeNewswire

Cytokinetics and Royalty Pharma Announce Expanded Strategic Funding Collaboration Totaling Up to $575 Million to Support Commercial Launch of Aficamten and to Advance R&D Pipeline
22/05/2024
Deal Provides Cytokinetics with Diversified Access to Capital as Company Advances Its Specialty Cardiology Franchise SOUTH SAN FRANCISCO, Calif. and NEW YORK, May 22, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated [...]
Inventiva announces two scientific presentations at the EASL International Liver Congress™ 2024
22/05/2024
The first abstract demonstrates that the improvements of MACK-3, a diagnostic test for metabolic dysfunction-associated steatohepatitis, parallel the histological response to lanifibranor therapy in patients with MASH/ [...]
Inventiva annonce deux présentations scientifiques lors de l’EASL International Liver Congress™ 2024
22/05/2024
Le premier abstract démontre un parallèle entre les améliorations du score MACK-3, un test de diagnostic de la stéatohépatite associée à un dysfonctionnement métabolique, et la réponse histologique au traitement par [...]
Media Conference - Update: Fightback to Save Durham Hospital Ratcheting Up
22/05/2024
TORONTO and GREY BRUCE, Ontario, May 22, 2024 (GLOBE NEWSWIRE) -- It is a small community, but it has raised its voice for the whole province to hear. Almost a thousand community members have taken to the streets in [...]
Bahrain Oncology Centre Amongst the First in the World to Offer Ground-breaking Sickle Cell and Transfusion Dependent Thalassemia Gene Therapy
22/05/2024
MUHARRAQ, Bahrain, May 22, 2024 (GLOBE NEWSWIRE) -- The Bahrain Oncology Centre (BOC) has achieved a significant milestone, becoming amongst the first centres in the World to offer the ground-breaking CASGEVY ( [...]
Virios Therapeutics Announces Closing of $1.7 Million Public Offering of Common Stock to Commence Preparations for Planned IMC-2 Long-COVID Phase 2b Study
22/05/2024
ATLANTA, May 22, 2024 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company” or “Virios Therapeutics”), a development-stage biotechnology company focused on advancing novel antiviral therapies to [...]
ONWARD® Medical organise une téléconférence pour partager les détails relatifs à son étude clinique Up-LIFT et à sa publication dans la revue Nature Medicine
22/05/2024
La revue Nature Medicine a publié les résultats de l’essai clinique pivot Up-LIFT ONWARD Medical présentera les résultats de cet essai pivot à l’occasion d’une téléconférence organisée cette semaine avec le concours de [...]
SOHM, Inc., Targets Revolutionary New ABBIE Genome Editing Kits for Q3, 2024
22/05/2024
SOHM, Inc. Further Advances its Work in the Field of Genome Editing and ABBIE, a Retroviral Integrase with Linked Guided DNA Binding Domain CHINO HILLS, Calif., May 22, 2024 (GLOBE NEWSWIRE) -- via IBN -- SOHM, Inc. ( [...]
GENFIT: May 22, 2024 Combined Shareholders Meeting Results
22/05/2024
Quorum of 27.25% on first convening; allowing approval of all the resolutions Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), May 22, 2024 - GENFIT (Nasdaq and Euronext: GNFT) , a late- [...]
GENFIT : Résultats de l’Assemblée Générale Mixte du 22 mai 2024
22/05/2024
Quorum de 27,25% obtenu sur première convocation ayant permis d’approuver l’ensemble des projets de résolutions Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 22 mai 2024 – GENFIT (Nasdaq et [...]
Syapse Expands Oncology Real-World Data Offerings with Introduction of Syapse Cohorts: Essentials
22/05/2024
WEST CHESTER, Pa., May 22, 2024 (GLOBE NEWSWIRE) -- Syapse, a leading real-world oncology data company announced the launch of its latest real-world data offering: Syapse Cohorts: Essentials . This new offering expands [...]
Guerbet : NUCLIDIUM et Guerbet concluent un partenariat stratégique pour soutenir le développement de la radiothéranostique ciblée basée sur des radio-isotopes de cuivre.
22/05/2024
COMMUNIQUE DE PRESSE NUCLIDIUM et Guerbet concluent un partenariat stratégique pour soutenir le développement de la radiothéranostique ciblée basée sur des radio-isotopes de cuivre L'accord allie l'expertise de pointe [...]
Guerbet : NUCLIDIUM and Guerbet Form Strategic Partnership to Support the Advancement of targeted Copper-based Radiotheranostics.
22/05/2024
NUCLIDIUM and Guerbet Form Strategic Partnership to Support the Advancement of targeted Copper-based Radiotheranostics -- Agreement brings together Guerbet’s industry leading expertise in medical imaging technologies, [...]
Combined General Meeting of May 22, 2024
22/05/2024
Press Release Approval of all resolutions put forward by the Board of Directors, including the unconsolidated and consolidated financial statements for the year 2023 Ratification of the co-option of Géraldine Leveau as [...]
Assemblée Générale Mixte du 22 mai 2024
22/05/2024
Communiqué de presse Approbation de l’ensemble des résolutions agréées par le Conseil d’administration, y compris les comptes sociaux et les comptes consolidés de l’exercice 2023 Ratification de la cooptation de [...]
GrayHawk Health Appoints Maria McCall as Senior Vice President of Operations
22/05/2024
MALVERN, Pa., May 22, 2024 (GLOBE NEWSWIRE) -- GrayHawk Health, a Health Empowerment Organization, is pleased to announce the appointment of Maria McCall as its Senior Vice President of Operations. With a distinguished [...]
Kymera Therapeutics Presents New Preclinical Data for KT-621, a First-In-Class, Oral STAT6 Degrader at the ATS Annual Meeting
22/05/2024
KT-621, a potent, selective, oral STAT6 degrader, demonstrated comparable or superior activity to dupilumab in preclinical studies including an asthma model shared at the ATS Annual Meeting Additional KT-621 preclinical [...]
Upstream Bio Presents Results from a Dose Ranging Study of Verekitug (UPB-101) in Adults with Asthma at the American Thoracic Society International Conference
22/05/2024
– In a multiple-ascending dose (MAD) study in patients with asthma, up to 54% reduction in fractional exhaled nitric oxide concentration (F E NO) was observed with administration of verekitug, with treatment effects [...]
A Bold Step Forward: Trial Equity and Miller Tanner Associates Partner to Champion Diversity in Clinical Research
22/05/2024
PHILADELPHIA, May 22, 2024 (GLOBE NEWSWIRE) -- Trial Equity and Miller Tanner Associates (MTA) are excited to announce a groundbreaking partnership aimed at expanding education and participation across diverse patient [...]

Pages